Page last updated: 2024-10-21

ethylisopropylamiloride and Muscular Atrophy, Spinal

ethylisopropylamiloride has been researched along with Muscular Atrophy, Spinal in 2 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Muscular Atrophy, Spinal: A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yuo, CY1
Lin, HH1
Chang, YS1
Yang, WK1
Chang, JG1
Burnett, BG1
Sumner, CJ1

Other Studies

2 other studies available for ethylisopropylamiloride and Muscular Atrophy, Spinal

ArticleYear
5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Annals of neurology, 2008, Volume: 63, Issue:1

    Topics: Alternative Splicing; Amiloride; Cell Line; Cell Survival; Cyclic AMP Response Element-Binding Prote

2008
Targeting splicing in spinal muscular atrophy.
    Annals of neurology, 2008, Volume: 63, Issue:1

    Topics: Amiloride; Cyclic AMP Response Element-Binding Protein; Exons; Gene Expression Regulation; Genetic P

2008